Rice Hall James & Associates, LLC Iovance Biotherapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 1,679,157 shares of IOVA stock, worth $15.2 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

1,679,157

Previous 1,636,025 2.64%

Holding current value

$15.2 Million

Previous $13.1 Million 20.18%

% of portfolio

0.93%

Previous 0.85%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$7.28 - $11.9 $314,000 - $513,270	43,132 Added 2.64%	1,679,157 $15.8 Million
Q2 2024 Aug 07, 2024	SELL	$7.78 - $14.19 $605,284 - $1.1 Million	-77,800 Reduced 4.54%	1,636,025 $13.1 Million
Q1 2024 Apr 23, 2024	SELL	$7.59 - $17.47 $281,452 - $647,822	-37,082 Reduced 2.12%	1,713,825 $25.4 Million
Q4 2023 Feb 08, 2024	BUY	$3.3 - $8.89 $93,046 - $250,662	28,196 Added 1.64%	1,750,907 $14.2 Million
Q3 2023 Nov 02, 2023	SELL	$4.44 - $8.79 $160,053 - $316,861	-36,048 Reduced 2.05%	1,722,711 $7.84 Million
Q2 2023 Jul 24, 2023	BUY	$5.36 - $9.06 $154,341 - $260,882	28,795 Added 1.66%	1,758,759 $12.4 Million
Q1 2023 May 11, 2023	SELL	$5.53 - $8.22 $509,401 - $757,193	-92,116 Reduced 5.06%	1,729,964 $10.6 Million
Q4 2022 Jan 27, 2023	BUY	$5.62 - $10.0 $2.18 Million - $3.88 Million	388,024 Added 27.06%	1,822,080 $0
Q3 2022 Nov 01, 2022	SELL	$9.53 - $13.11 $2.55 Million - $3.5 Million	-267,135 Reduced 15.7%	1,434,056 $13.7 Million
Q2 2022 Aug 08, 2022	BUY	$6.38 - $18.33 $3.93 Million - $11.3 Million	616,070 Added 56.77%	1,701,191 $18.8 Million
Q1 2022 May 05, 2022	BUY	$12.38 - $19.1 $5.61 Million - $8.66 Million	453,337 Added 71.76%	1,085,121 $18.1 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $3.81 Million - $6.36 Million	-230,163 Reduced 26.7%	631,784 $12.1 Million
Q3 2021 Nov 09, 2021	SELL	$20.35 - $26.63 $436,466 - $571,160	-21,448 Reduced 2.43%	861,947 $21.3 Million
Q2 2021 Jul 29, 2021	BUY	$16.33 - $33.07 $2.9 Million - $5.87 Million	177,468 Added 25.14%	883,395 $23 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $156,853 - $287,719	-5,471 Reduced 0.77%	705,927 $22.4 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $798,354 - $1.43 Million	-28,472 Reduced 3.85%	711,398 $33 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $1.66 Million - $2.18 Million	59,933 Added 8.81%	739,870 $24.4 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $6.19 Million - $9.33 Million	227,595 Added 50.31%	679,937 $18.7 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $8.84 Million - $17.6 Million	452,342 New	452,342 $13.5 Million

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.43B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Iovance Biotherapeutics, Inc. Transaction History